Desvenlafaxine

Major Depressive Disorder

Desvenlafaxine is used to treat major depressive disorder (MDD). This condition is a medical illness characterized by a persistent low mood, feelings of sadness or hopelessness, and a loss of interest in activities that were once enjoyable.

Healthcare providers prescribe this medication to help manage the emotional and physical symptoms of depression. It is intended to help restore a person's ability to function in daily life by improving several key areas, including:

• Overall mood and emotional well-being
• Energy levels and motivation
• Sleep patterns and appetite
• Interest in social and professional activities

Desvenlafaxine is typically used as a long-term treatment for adults. It belongs to a class of medications known as serotonin and norepinephrine reuptake inhibitors (SNRIs), which are used to help regulate certain chemicals in the brain that affect mood.

How Desvenlafaxine Works

Desvenlafaxine belongs to a group of medications called serotonin and norepinephrine reuptake inhibitors (SNRIs). It is used to treat depression by affecting the balance of chemicals in the brain.

The medication works by targeting two specific neurotransmitters, which are chemical messengers that allow nerve cells to communicate with each other:

• Serotonin: This chemical plays a key role in regulating mood, sleep, and appetite.
• Norepinephrine: This chemical is involved in energy levels, focus, and the body's response to stress.

In a typical brain process, these chemicals are released by one nerve cell and then reabsorbed by the brain after the message is delivered. This reabsorption is called reuptake. Desvenlafaxine works by blocking this reuptake process. By preventing the brain from reabsorbing these chemicals too quickly, the medication increases the amount of serotonin and norepinephrine available to send signals between nerve cells.

Although the precise biological mechanism that leads to an improvement in depression symptoms is not completely understood, it is believed that increasing the availability of these neurotransmitters helps restore mental balance and improve mood.

Common Side Effects

Many people using desvenlafaxine experience mild side effects that often improve as the body adjusts to the medication. Common side effects include:

• Nausea or vomiting
• Dizziness or drowsiness
• Increased sweating
• Dry mouth
• Constipation
• Loss of appetite
• Difficulty sleeping (insomnia)
• Feeling tired or weak
• Anxiety or jitteriness

Serious Side Effects

Contact a healthcare provider immediately if you experience any of the following serious symptoms:

• Signs of an allergic reaction, such as hives, skin rash, or swelling of the face, lips, or throat
• Seizures
• Unusual bruising or bleeding
• Vision changes, eye pain, or redness in or around the eye
• High blood pressure
• Low sodium levels, which may cause headache, confusion, or severe weakness

Serotonin Syndrome: This is a rare but life-threatening condition. Seek emergency care for symptoms such as hallucinations, rapid heart rate, fever, severe muscle stiffness, or loss of coordination.

Sexual Side Effects

Some individuals may experience changes in sexual function while taking this medication. These can include a decreased interest in sex, difficulty achieving orgasm, or erectile dysfunction in men.

Suicidal Thoughts and Behaviors

Desvenlafaxine and other antidepressant medicines may increase suicidal thoughts or actions in children, teenagers, and young adults. This risk is highest during the first few months of treatment or when the dose is changed. It is important to watch for new or worsening depression, anxiety, panic attacks, or other unusual changes in behavior or mood.

Serotonin Syndrome

A serious condition called serotonin syndrome can occur when desvenlafaxine is taken with other drugs that affect serotonin. This includes certain migraine medications (triptans), other antidepressants, and some pain medications. Symptoms may include agitation, hallucinations, rapid heart rate, dizziness, sweating, flushing, and muscle stiffness.

Blood Pressure Monitoring

Treatment with desvenlafaxine can lead to increases in blood pressure. Healthcare providers typically measure blood pressure before starting the medication and monitor it regularly throughout treatment. Pre-existing high blood pressure should be controlled before starting this drug.

Bleeding Risks

This medication may increase the risk of bleeding. This is more likely if it is taken with aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, or blood thinners. Symptoms of abnormal bleeding can include bruising easily or nosebleeds.

Discontinuation Symptoms

Stopping desvenlafaxine suddenly can cause withdrawal-like symptoms. These may include dizziness, nausea, headache, irritability, and sleep disturbances. A healthcare provider will usually recommend a gradual dose reduction when stopping the medication.

Other Precautions

• Bipolar Disorder: Desvenlafaxine may trigger a manic episode. Individuals should be screened for bipolar disorder before starting treatment.
• Seizures: Caution is advised for those with a history of seizures.
• Glaucoma: This drug may cause pupillary dilation, which can trigger an angle-closure attack in people with certain eye conditions.
• Low Sodium: Hyponatremia (low blood sodium) can occur, particularly in older adults or those taking diuretics.

Pregnancy

Taking desvenlafaxine during the third trimester of pregnancy may lead to complications in the newborn. Some infants exposed to this type of medication late in pregnancy have developed problems shortly after birth, including:

• Breathing difficulties or rapid breathing
• Feeding problems
• Seizures
• Muscle stiffness or limpness
• Constant crying or irritability
• Jitteriness and tremors
• Low blood sugar

These symptoms may be due to the direct effects of the drug or a withdrawal reaction. However, untreated depression during pregnancy also poses significant risks to both the mother and the baby. Stopping the medication abruptly can cause a relapse of symptoms. It is important to discuss the risks and benefits of continuing or stopping treatment with a healthcare provider.

Breastfeeding

Desvenlafaxine passes into breast milk. Because the effects on a nursing infant are not fully understood, it is necessary to consult a doctor before breastfeeding while taking this medication. A healthcare provider can help weigh the benefits of breastfeeding against the potential risks and may recommend monitoring the infant for any unusual symptoms.

Available Forms

Desvenlafaxine is provided in the following form for oral administration:

• Extended-release tablet: This is a long-acting formulation designed to be taken once daily.

The extended-release tablets are film-coated and are intended to be swallowed whole. They should not be crushed, chewed, or dissolved, as doing so can release the entire dose of medication at once.

FDA Approval and Indications

Desvenlafaxine is approved by the U.S. Food and Drug Administration (FDA) for the treatment of major depressive disorder (MDD) in adults. It belongs to a class of medications known as serotonin and norepinephrine reuptake inhibitors (SNRIs).

Boxed Warning

The FDA requires a boxed warning for desvenlafaxine, which is the most serious type of warning for prescription medications. This warning states that antidepressants may increase the risk of suicidal thoughts and behaviors in children, adolescents, and young adults up to age 24. Healthcare providers and caregivers should closely monitor patients of all ages for clinical worsening, suicidal ideation, or unusual changes in behavior, especially during the initial months of therapy or following dosage adjustments.

Pediatric Use

The safety and effectiveness of desvenlafaxine in pediatric patients have not been established. The medication is not FDA-approved for use in children or adolescents under the age of 18.

Regulatory Status

Desvenlafaxine is available only by prescription. It is provided as extended-release tablets designed to release the medication into the body over a period of time.

Withdrawal Symptoms

Stopping desvenlafaxine abruptly can lead to discontinuation symptoms. These effects may occur within a few days of missing a dose or stopping the medication entirely. Common withdrawal symptoms include:

• Dizziness, nausea, and headache
• Irritability, anxiety, or agitation
• Confusion and mood swings
• Tiredness or trouble sleeping
• Sweating, shaking, or tremors
• Sensations of numbness or tingling in the hands or feet

Safe Discontinuation

To avoid these symptoms, healthcare providers typically recommend a gradual tapering process. This involves slowly lowering the dose over several weeks or months. If symptoms become severe during this process, your doctor may slow the tapering schedule.

Never stop taking desvenlafaxine or change your dose without medical supervision, as sudden changes can significantly impact your well-being.